Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5300 (1.31%) ($8.5300 - $8.5300) on Mon. May. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 73 | Latest Price | $8.5300(1.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(28%) XLRE(27%) BND(25%) CEMB(25%) SDY(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.3% in a week (0% probabilities). VIXM(-26%) VXX(-25%) TLT(-15%) VCIT(-12%) LQD(-11%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.46(0.83%) | 10 Day Moving Average | $8.5(0.35%) | 20 Day Moving Average | $8.21(3.9%) | To recent high | -11.5% | To recent low | 15.7% | Market Cap | $1.505b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |